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Abstract
Background: Benzathine penicillin G every 3 weeks is the standard protocol for secondary prophylaxis for recurrent 
rheumatic fever.
Objective: Assess the effect of Benzathine penicillin G on Streptococcus sanguinis and  in patients 
with cardiac valvular disease due to rheumatic fever receiving secondary prophylaxis.
Methods: Oral streptococci were evaluated before (baseline) and 7 days (day 7) after Benzathine penicillin G in 100 
patients receiving routine secondary rheumatic fever prophylaxis. Saliva samples were evaluated for colony count and 
presence of S. sanguinis and S. oralis. Chewing-stimulated saliva samples were serially diluted and plated onto both 
nonselective and selective 5% sheep blood agar containing penicillin G. The species were identified using conventional 
biochemical tests. Minimal inhibitory concentrations were determined with the Etest. 
Results: No statistical differences were found in the presence of S. sanguinis comparing baseline and day 7 (p = 
0.62). However, the existing number of positive cultures of S. oralis on day 7 after Benzathine penicillin G presented a 
significant increase compared to baseline (p = 0.04). No statistical difference was found between baseline and day 7 
concerning the number of S. sanguinis or S. oralis CFU/mL and median minimal inhibitory concentrations.
Conclusion: This study showed that Benzathine penicillin G every 3 weeks did not change the colonization by S. 
sanguinis, but increased colonization of S. oralis on day 7 of administration. Therefore, susceptibility of Streptococcus 
sanguinis and Streptococcus oralis to penicillin G was not modified during the penicillin G routine secondary rheumatic 
fever prophylaxis. (Arq Bras Cardiol 2012;98(5):452-458)
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RF with BPG. Also, none of the studies have assessed this issue 
related to S. sanguinis and S. oralis, which are predominant 
species recovered in IE7,8. 
BPG prophylaxis protects valvular heart disease patients 
of new RF recurrences. However, no study has evaluated the 
oral flora with an expressive casuistic and specificity for these 
pathogens. 
Therefore, the aim of this study is to evaluate if there is an 
association between BPG prophylaxis and the colonization of 
oral cavity by penicillin resistant Viridans Streptococci.
Methods
Cohort
A hundred patients were selected and evaluated in 2 
periods:
BPG baseline and day 7 – One hundred RF patients 
previously receiving a secondary prophylaxis regimen with 
benzathine penicillin G 1,200,000 IU for at least 6 months 
before study admission. Patients with rheumatic activity or 
patients with diagnosis of infection were excluded.
Introduction
Rheumatic fever (RF) is the leading cause of valvular heart 
disease in developing countries. RF causes significant morbidity 
and mortality, causing 90% of cardiac surgeries in children and 
over 30% of cardiac surgeries in adults. Secondary prophylaxis of 
1,200,000 U benzathine penicillin G (BPG) every 3 weeks is the 
standard regimen for the prevention of recurrent rheumatic fever 
in developing countries. Valvular sequelae is the most dreadful 
consequence of acute rheumatic fever, and such cardiac lesions 
can also predispose a patient to infective endocarditis (IE), a 
morbid disease that worsens the prognosis of these patients1-4.
In spite of the widely recommended secondary prophylaxis 
of RF with BPG every 3 weeks2,5,6, very few studies have assessed 
the antibiotic susceptibility and frequency of Viridans Streptococci 
in the oral flora of patients receiving secondary prophylaxis after 
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All patients were assessed clinically, and they underwent 
oral cavity inspection to avoid admission of patients with acute 
systemic or oral infection.
This study was approved by the institutional ethics committee, 
and all study patients gave informed consent.
Sample collection, transport, and culture
Samples were collected at baseline (100 samples) and day 
7 (100 samples) after BPG prophylactic dosage. Saliva samples 
were obtained from patients who chewed paraffin tablets9 and 
were collected into a sterile disposable plastic vial. Approximately 
1 mL was transferred to a vial containing 5.7 mL of Göteborg 
viability medium, anaerobically prepared and sterilized (VMGA 
II S)10. Samples in transport medium were maintained at 2ºC to 
8ºC before plating. Saliva samples were serially diluted tenfold 
in phosphate-buffered solution pH 7.2 before plating onto 
Columbia nalidixic agar plus 5% sheep blood (CNASB), CNASB 
plus penicillin G (0.25 µg/mL)11, and amphotericin B (0.5 µg/
mL)12-15. Media were incubated at 35ºC in 5% CO2 for 72 h and 
then analyzed for colony count for each colonial morphotypes.
Species identification
Each colony morphotype was subcultivated onto tryptic soy 
agar plus 5% sheep blood (SBA) and tested for catalase and Gram 
stain. Catalase negative Gram-positive cocci were subsequently 
evaluated for the following characteristics/substrate utilization: 
hemolysis, arginine, urea, L-pyrrolidonyl-β-naphthylamide and 
esculin hydrolysis, β-N-acetyl glycosidase, α-D-glycosidase, β-N-
acetyl galactosidase, optochin susceptibility, Voges-Proskauer 
test, and acid production from inulin, mannitol, raffinose, and 
melibiose, as recommended16. 
Susceptibility testing
Minimal inhibitory concentration (MIC) for penicillin G 
was determined using the Etest as recommended by the 
manufacturer (AB Biodisk, Solna, Sweden). Results were 
interpreted as recommended by the Clinical and Laboratory 
Standards Institute (CLSI)11.
Statistical analysis
The Logistic Regression model was used to check the group’s 
association with the occurrence of S. sanguinis and S. oralis with 
age and sex corrections.
The qualitative analysis was performed using the Mc Nemar 
nonparametric test.
Quantitative analysis was performed with the use do the 
Wilcoxon nonparametric test.
Statistical significance of 5% was applied for all tests.
Results
The group studied was composed of 100 patients, 38 males, 
aged 10 to 53 years old (26.5 ± 8 years).
In the group, 54 patients had mitral regurgitation, 27 had aortic 
regurgitation, 25 had mitral stenosis, and 14 had aortic stenosis. 
Eight patients had biological mitral prosthesis, 3 had biological 
aortic prosthesis, 2 had mechanical mitral prosthesis, and 1 had 
mechanical aortic prosthesis.
There were no differences comparing the number of positive 
cultures existed for S. sanguinis at baseline and day 7 after BPG 
(p = 0.62, Table 1). However, the existing number of positive 
cultures for S. oralis at day 7 after BPG presented a significant 
increase compared to baseline (p = 0.04, Table 1).
The assessments of the CFU/mL number in saliva of the 
patients at baseline and day 7 after BPG were subdivided into 
S. sanguinis and S. oralis.
The CFU/mL values in saliva for S. sanguinis and S. oralis did 
not differ between baseline and day 7 after BPG (p = 0.68 and 
p = 0.80 respectively; Figure 1).
The minimal inhibitory concentrations for penicillin G values 
were subdivided into S. sanguinis and S. oralis. No statistical 
difference was found between baseline and day 7 after BPG 
concerning the MIC of S. sanguinis and S. oralis (p = NS; Figure 2).
Table 2 shows data as MIC50 and MIC90, which represents the 
minimal inhibitory concentrations for penicillin G to inhibit 50% 
and 90%, respectively, of the susceptible Streptococcus sanguinis 
and Streptococcus oralis to penicillin G.
Discussion
This group of patients with valvular heart disease is 
predisposed to infective endocarditis. Infective endocarditis 
results from bacteremia, often related to oral infectious focuses. 
Viridans streptococci are the predominant group recovered in 
IE, particularly Streptococcus sanguinis and Streptococcus oralis. 
The effect of chronic BPG has not been studied with specificity 
to these pathogens yet.22,23
The study cohort had a prevalence of females (62/100), 
possibly due to the higher general occurrence of RF in women17. 
Despite the gender heterogeneity, it did not represent a bias 
because no statistical difference existed (p = NS) between the 
occurrence of S. sanguinis an S.oralis in relation to the patients 
age and sex when we applied the logistic regression model. 
Furthermore, no statistical difference existed among the rate 
of tooth cavities, loss of teeth, or teeth with fillings between 
sexes in the study population18. All patients had their oral 
cavities inspected according to the criteria of the World Health 
Organization19 to exclude the presence of oral infections, which 
could affect the oral microbiota16,20-22.
S. sanguinis and S. oralis are common commensals of the oral 
cavity present in the initial formation of dental bacterial plaque, 
representing nearly 80% Streptococcus in this phase20-23. The BPG 
1,200,000 IU IM dose exercises as a bactericide effect on the 
Streptococcus, sensitive in the active multiplication phase, which, 
hypothetically, would cause a decrease in these microorganisms 
in the oral cavity in this group of patients.
S. sanguinis was also observed in both periods in a limited 
number of patients, similarly to that observed by Bilavsky et al7. 
No difference (P=0.62) of its presence was noticed in the study 
groups. This showed that BPG did not interfere with the species 
growth. However, other studies reported a greater number of 
samples of S. sanguinis20,21, perhaps due to the use of classic 
methodology for Streptococcus identification (with the use of 
commercially available identification kits in conjunction with 
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Table 1 – Positive cultures for Streptococcus sanguinis and Streptococcus oralis
Groups Streptococcus sanguinis Streptococcus oralis
Baseline* 11 87
Day 7† 9 95‡
*Patients before benzathine penicillin G dosage; †Patients under benzathine penicillin G 7 day effect; ‡p = 0.04.
Figure 1 – A1 - Distribution of CFU/mL values in saliva in patients colonized by S. sanguinis; A2 - distribution of CFU/mL values in saliva in patients colonized 
by S. oralis.
CFU/mL (in millions)
n = number of 
colonized patients 
(P = 0,68)
Baseline (n = 11) Day 7 (n = 9)
Streptococcus sanguinis
CFU/mL (in millions)
n = number of 
colonized patients 
(P=0,80)
Baseline (n = 87) Day 7 (n = 95)
Streptococcus oralis
A1
A2
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Figure 2 – B1 - distribution of MIC values in µg/mL for S. sanguinis; B2 - distribution of MIC values in µg/mL for S. oralis
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Table 2 – MIC50 and MIC90 (µg/mL) and group distribution according to Streptococcus sanguinis and Streptococcus oralis susceptibility to penicillin
Baseline‡ Day 7§
S. sanguinis S. oralis S. sanguinis S. oralis
MIC50* 0.190 0.250 0.250 0.250
MIC90† 0.380 1.000 0.500 1.000
Sensitive 45.5% (5/11)
44.8% 
(39/87)
33.3% 
(3/9)
41.1% 
(39/95)
Intermediary resistance 45.5% (5/11)
55.2% 
(48/87)
66.7% 
(6/9)
58.9% 
(56/95)
High level resistance 9% (1/11) - - -
*MIC50 – minimal inhibitory concentration for penicillin G to inhibit 50% of the susceptible Streptococcus sanguinis and Streptococcus oralis. †MIC90 – minimal 
inhibitory concentration for penicillin G to inhibit 90% of the susceptible Streptococcus sanguinis and Streptococcus oralis. ‡Patients before benzathine penicillin G 
dosage. §Patients under benzathine penicillin G 7 day effect. P = NS.
standard screening tests for the genre). Nevertheless, in this 
study the methodology described by Ruoff et al16 was adopted, 
performing biochemical tests with the addition of 3 fluorogenic 
substrates, increasing the specificity in the identification of the 
species. Although we have used the best methodology available 
for the identification of these species, it is known that there are 
some limitations, since genetic sequencing would certainly be the 
best method to be applied. However, this would be financially 
impractical due to the sample size, probably leading to no 
difference in the result of the study.
In regard to obtaining the samples through stimulated saliva 
and not from the dental plaque, this was due to an overall 
knowledge that stimulated saliva is a better collection method 
for its homogeneity and logistics compared to the collection of 
dental plaque samples24.
As for the S. oralis, we noticed a significantly higher number 
of these microorganisms in the BPG-day 7 vs. baseline (p = 
0.04, Table 1). The saliva sample collected from BPG- day 7 
occurred during the time of the greatest amount of serum drug 
concentration according to Decourt et al25. This is evidence of the 
lack of BPG influence on the most prevalent microorganism in 
the bacterial plaque and one of the main Infectious Endocarditis 
etiological agents20,21,26.
In this study, we found no statistical difference concerning 
saliva UFC/mL numbers (Figure 1, p = NS) and MICs (MIC50 and 
MIC90) of S. sanguinis and S. oralis (Table 2).
The chronic use of benzathine penicillin G in the study group 
did not significantly alter S. sanguinis and S. oralis susceptibility 
to penicillin G, as seen previously7. It is interesting to note the 
occurrence of an increase in the resistance, or MIC values, in 
Viridans Streptococcus and, therefore, an increase in the number 
of strains resistant to antibiotics isolated into positive hemocultures 
for IE. However, these patients were receiving oral antibiotic 
therapy, and MIC intervals differ from those standardized by 
CLSI for penicillin G7,27,28.
Our findings regarding the identification of species corroborate 
the results of Bilavsky et al7. However, we disagree with the 
increased resistance to penicillin G of Viridans Streptococcus.
This study contributed to awake a inquiry regarding the 
clinical treatment of these patients. Although the American Heart 
Association (AHA) no longer recommends antibiotic prophylaxis 
prior to procedures that cause bacteremia in these patients, we 
believe that further studies are required aimed at the Brazilian 
population to know our reality, and then adapt it to changes 
suggested by the AHA. While we are awaiting these data, it would 
be prudent to continue to implement the recommendations 
of the 1997 AHA guidelines, in which prophylaxis for infective 
endocarditis is recommended for patients with rheumatic 
heart disease prior to procedures that cause bacteremia in the 
genitourinary tract, respiratory tract and the stomatognathic system.
Our study also contributes to the interface between medicine 
and dentistry, because it shows that under the prolonged action 
of PGB, there is no decrease of the main microorganisms 
involved in the etiology of infective endocarditis and, therefore, 
antibiotic prophylaxis prior to procedures that cause bacteremia 
may be necessary.
Hence, additional studies are necessary to verify the need 
to establish a special routine so that these patients can undergo 
dental procedures that could cause bacteremia on the 7th day 
following the administration of BPG.
This study showed that BPG every 3 weeks did not change 
the colonization by S. sanguinis; but BPG increased S. oralis 
colonization on day 7 following its administration and, finally, 
susceptibility of Streptococcus sanguinis and Streptococcus oralis 
to penicillin G was not altered during the penicillin G cycle.
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